Plains GP Holdings (PAGP) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Feb, 2026Executive summary
Reported Q4 2025 adjusted EBITDA of $738 million and full-year 2025 adjusted EBITDA of $2.833 billion, with 2026 guidance at $2.75 billion (+/- $75 million), despite a challenging market.
Transitioned to a pure-play crude company by selling the NGL business and acquiring the Cactus III (EPIC) pipeline, streamlining operations and improving cash flow quality.
Announced a 10% annualized distribution increase to $1.67 per unit and lowered the coverage ratio target from 160% to 150%.
2026 initiatives include closing the NGL divestiture, integrating Cactus III, and achieving $100–$150 million in annual cost savings by 2027, with half expected in 2026.
Achieved best-ever safety performance in 2025, with record low TRIR and lost workdays.
Financial highlights
Q4 2025 crude oil segment adjusted EBITDA was $611 million, including two months of Cactus III contribution.
NGL segment Q4 adjusted EBITDA was $122 million, with seasonal uptick moderated by warm weather and weak frac spreads.
2026 adjusted EBITDA guidance is $2.75 billion at midpoint, with oil segment EBITDA of $2.64 billion, implying 13% year-over-year growth in crude.
2026 adjusted free cash flow projected at ~$1.8 billion, excluding asset/liability changes and NGL sale proceeds.
Full-year 2025 revenue was $44.26 billion, down from $48.89 billion in 2024.
Outlook and guidance
2026 guidance assumes NGL divestiture closes by end of Q1, with $100 million EBITDA from NGL and $10 million other income.
Permian crude production forecasted flat year-over-year in 2026, with growth expected to resume in 2027.
Annualized distribution increased to $1.67 per unit, with targeted annual growth of $0.15 per unit and a reduced coverage ratio threshold of 150%.
Leverage ratio expected to return to the 3.25–3.75x target range post-NGL sale.
Growth capital for 2026 guided at $350 million, maintenance capital at $165 million.
Latest events from Plains GP Holdings
- Exceeded guidance, raised distributions, and forecasted growth driven by acquisitions and Permian strength.PAGP
Q4 20249 Feb 2026 - Q2 2024 Adjusted EBITDA beat expectations; full-year guidance raised on strong execution.PAGP
Q2 20249 Feb 2026 - Q3 Adjusted EBITDA $659M, leverage 3.0x, and Moody's upgrade support strong 2024 outlook.PAGP
Q3 202415 Jan 2026 - Strong 2024 results, disciplined capital returns, and robust governance drive value creation.PAGP
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and executive pay are up for vote at the 2025 meeting.PAGP
Proxy Filing2 Dec 2025 - Q1 2025 net income up 67%, Adjusted EBITDA $754M, strong growth and strategic acquisitions.PAGP
Q1 202526 Nov 2025 - Q2 Adjusted EBITDA $672M; NGL sale and acquisitions boost financial flexibility and focus.PAGP
Q2 202523 Nov 2025 - Q3 2025 EBITDA hit $669M; net income doubled, with acquisitions and NGL sale refocusing strategy.PAGP
Q3 202513 Nov 2025 - Raised 2024 EBITDA guidance and delivered strong free cash flow with efficient growth.PAGP
Investor Reception Presentation25 Jun 2025